Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04237701 · ClinicalTrials.gov registry record
Real-Time Monitoring of Heart Failure Across the Yale New Haven Health System
A clinical trial of Heart Failure and Heart Failure With Preserved Ejection Fraction, sponsored by Yale University.
- Recruiting
- Registry status
- 40,000
- Enrollment target
- 1
- Study location
NCT04237701 is a study of Heart Failure and Heart Failure With Preserved Ejection Fraction that is actively recruiting participants, run by Yale University. The registered enrollment target is 40,000 participants, above the 1,948-participant average among 397 other Heart Failure trials with a reported enrollment target (1953% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04237701, a study of Heart Failure and Heart Failure With Preserved Ejection Fraction, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- 40,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The Yale HF Registry is a live EHR based registry that allows for retrospective and real-time monitoring of Heart Failure case across the Yale New Haven Health System.
Conditions Studied
Study Locations (1)
Connecticut
- Yale New Haven Health System - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40,000 participants |
| Start Date | 2019-10-01 |
| Est. Completion | 2030-12-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04237701
The ClinicalTrials.gov registry entry for NCT04237701 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 40,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,948-participant average among 397 other Heart Failure trials with a reported enrollment target (1953% higher). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Heart Failure appearing as the primary indexed condition, and to 0 interventions.
NCT04237701 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT04237701 about?
NCT04237701 is a clinical study titled "Real-Time Monitoring of Heart Failure Across the Yale New Haven Health System". The Yale HF Registry is a live EHR based registry that allows for retrospective and real-time monitoring of Heart Failure case across the Yale New Haven Health System.
What is the current status of trial NCT04237701?
This trial is currently recruiting. The enrollment target is 40,000 participants. The study started on 2019-10-01. Estimated completion is 2030-12-30.
What conditions does trial NCT04237701 study?
This clinical trial studies the following conditions: Heart Failure, Heart Failure With Preserved Ejection Fraction, Heart Failure With Reduced Ejection Fraction, Heart Failure NYHA Class IV.
Who is sponsoring clinical trial NCT04237701?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04237701 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Explore more on PlainTrial
Heart Failure
All registered trials for this condition
Heart Failure With Preserved Ejection Fraction
All registered trials for this condition
Connecticut
All trials with a study site in Connecticut
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.